A
Apontis Pharma AG
XETRA:APPH
Apontis Pharma AG
XETRA:APPH
Price:
11.25
EUR
2.27%
Market Closed
Market Cap:
95.6m
EUR
Cash Flow Statement
Cash Flow Statement
Apontis Pharma AG
Apontis Pharma AG
Currency: EUR
Millions
TTM
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(1)
|
4
|
3
|
(3)
|
(11)
|
0
|
(7)
|
0
|
|
| Depreciation & Amortization |
2
|
2
|
2
|
2
|
2
|
0
|
2
|
0
|
|
| Other Non-Cash Items |
6
|
3
|
2
|
(1)
|
0
|
0
|
(1)
|
0
|
|
| Cash Taxes Paid |
(0)
|
(0)
|
0
|
1
|
0
|
0
|
1
|
0
|
|
| Cash Interest Paid |
2
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(4)
|
(3)
|
4
|
(1)
|
(3)
|
(6)
|
(2)
|
(5)
|
|
| Cash from Operating Activities |
3
N/A
|
6
+67%
|
11
+92%
|
(3)
N/A
|
(13)
-333%
|
(15)
-22%
|
(7)
+51%
|
(9)
-15%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
0
|
(3)
|
0
|
|
| Other Items |
(0)
|
(0)
|
1
|
1
|
0
|
(0)
|
0
|
(1)
|
|
| Cash from Investing Activities |
(2)
N/A
|
(3)
-78%
|
(3)
+15%
|
(2)
+24%
|
(3)
-43%
|
(3)
-14%
|
(3)
+24%
|
(3)
-33%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
40
|
(1)
|
(2)
|
(1)
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(12)
|
0
|
0
|
0
|
6
|
0
|
(0)
|
0
|
|
| Other |
(8)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(6)
|
|
| Cash from Financing Activities |
20
N/A
|
(1)
N/A
|
(2)
-111%
|
(1)
+48%
|
6
N/A
|
6
N/A
|
(0)
N/A
|
(0)
+21%
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
22
N/A
|
2
-92%
|
7
+280%
|
(6)
N/A
|
(10)
-61%
|
(13)
-34%
|
(10)
+20%
|
(12)
-19%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
2
N/A
|
3
+50%
|
8
+191%
|
(6)
N/A
|
(16)
-176%
|
(15)
+3%
|
(10)
+34%
|
(9)
+15%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
